What is the Concord Biotech Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 7.28% of the total equity shares of Concord Biotech Ltd.

What is the Concord Biotech Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 10.95% of the total equity shares of Concord Biotech Ltd.

How has the Concord Biotech Ltd promoter holding changed?

The promoter holding in Concord Biotech Ltd changed from 44.08% to 44.09% during the latest reported period.

How has the Concord Biotech Ltd FII holding changed?

The FII holding in Concord Biotech Ltd changed from 7.52% to 7.28% during the latest reported period.

How has the Concord Biotech Ltd DII holding changed?

The DII holding in Concord Biotech Ltd changed from 9.36% to 10.95% during the latest reported period.

Who are the major shareholders of Concord Biotech Ltd?

The major shareholders of Concord Biotech Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Concord Biotech Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Concord Biotech Ltd public shareholding?

Public shareholders hold 37.68% of the total equity shares of Concord Biotech Ltd as per the latest available data.

Concord Biotech Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹1,229.30

-41.40(-3.26%)

As on 23 Oct 2026 at 15:54

As of 23 Oct 2026 at 15:54, Concord Biotech Ltd is trading at ₹1,229.30. The 52-week range stands at ₹987.00–₹1,615.00, with a market cap of ₹12.86 thousand crore. At a P/E of 45.21 and a dividend yield of 0.61%, it is a mid-cap stock in the Pharmaceuticals sector.